Mavuto Mukaka, Marie A Onyamboko, Peter Olupot-Olupot, Pimnara Peerawaranun, Kanokon Suwannasin, Watcharee Pagornrat, Jindarat Kouhathong, Wanassanan Madmanee, Winifred Were, Cate Namayanja, Peter Onyas, Harriet Titin, Joy Baseke, Rita Muhindo, Daddy K Kayembe, Pauline O Ndjowo, Benjamin B Basara, Georgette S Bongo, Charles B Okalebo, Grace Abongo, Sophie Uyoga, Thomas N Williams, Chiraporn Taya, Mehul Dhorda, Arjen M Dondorp, Naomi Waithira, Mallika Imwong, Kathryn Maitland, Caterina Fanello, Nicholas P J Day, Joel Tarning, Nicholas J White, Walter R J Taylor
BACKGROUND: There are no pharmacokinetic data of single low dose primaquine (SLDPQ) as transmission blocking in African children with acute Plasmodium falciparum and glucose-6-phosphate dehydrogenase deficiency (G6PDd). METHODS: Primaquine pharmacokinetics of age-dosed SLDPQ (shown previously to be gametocytocidal with similar tolerability as placebo) were characterised in falciparum-infected Ugandan and Congolese children aged 6 months to 11 years, treated on admission with standard 3-day dihydroartemisinin-piperaquine or artemether-lumefantrine plus SLDPQ: 6 m-<1 y: 1...
September 25, 2023: EBioMedicine